5 ms·
My counter to that question is - does it matter? This is basically a real world test of the vaccine. If it failed to meet it's endpoint for either reason, it'
by refurb 5y ago
My counter to that question is - does it matter? This is basically a real world test of the vaccine. If it failed to meet it's endpoint for either reason, it's not a suitable vaccine.
- makomk 5y agoAll the existing, currently approved vaccines weren't tested in the current real world in this way - their clinical trials were done in an environment that mostly predated the modern variants, which is where the numbers for them in the article come from. We know they're less effective against the variants but don't know how well they'd do in a present-day clinical trial like this one.
- MattPalmer1086 5y agoI guess it might matter for understanding why it doesn't perform as well, which is a legitimate question to answer that may help guide future vaccine development.
- tchalla 5y agoYes, it does. The other vaccines weren't tested on "real world" either. Therefore, a comparison to the "standard of care" (other vaccines) instead of control.
- refurb 5y agoBut they are producing follow up data for new variants. They are still effective against new variants. So test new vaccines as the Curevac was tested. If it fails we have all the info we need for that vaccine. https://www.ctvnews.ca/health/coronavirus/vaccines-effective-at-preventing-hospitalization-from-delta-variant-studies-suggest-1.5470525 https://www.ctvnews.ca/health/coronavirus/vaccines-effective...